Chapter 10 Schizophrenia
16 questions in this chapter
Chapter notesQ1According to DSM-5-TR criteria, which of the following are characteristics of schizophrenia? (More than one answer may apply.)
Q2Mrs. Engle is a 75-year-old woman with a 40-year history of type 2 diabetes mellitus who is referred for consultation of new-onset visual hallucinations. She describes seeing pictures of familiar scenes and people, but does not hear voices. She is aware that these images are not real, and during periods of hallucinations she is lucid and alert. She has no cognitive impairment and no past psychiatric history. Her vision has been slowly deteriorating for the past seven years due to macular degeneration. Which of the following is the most likely explanation for this patient?
Q3A PMHNP evaluates a 24-year-old male brought to the clinic by his family due to a gradual six-month decline in functioning. The patient has dropped out of college, stays in his room, avoids eye contact, and speaks in brief one-word answers. He denies hearing voices or having paranoid fears. Which of the following clinical features represents a negative symptom of schizophrenia?
Q4A 28-year-old female diagnosed with schizophrenia is being evaluated during a routine follow-up visit. The patient exhibits blunted affect, poor eye contact, and reports no motivation to seek employment or engage in social activities. The PMHNP considers switching her medication to better address these persistent deficits. Which class of psychotropic medications is preferred for improving negative symptoms in schizophrenia?
Q5A 22-year-old patient is newly diagnosed with schizophrenia and is at an outpatient appointment with his parents. Which of the following does the PMHNP realize is the most critical task to complete at this visit?
Q6The PMHNP would anticipate that treatment commonly employed to reduce the morbidity of schizophrenia would include all of the following EXCEPT
Q7A 34-year-old male is brought into the ED with symptoms of muscle rigidity, hyperthermia, and altered mental status. He has been receiving fluphenazine for the past three weeks and initiated lithium therapy only recently. An expected finding from this patient is
Q8A 28-year-old male with schizophrenia is being started on olanzapine for acute psychotic symptoms. Prior to initiating treatment, the PMHNP orders a baseline fasting lipid panel, fasting plasma glucose, and BMI. According to national monitoring guidelines, at what timeframe should the fasting plasma glucose and lipid panel be rechecked?